Gateway 2011: WellSpring Pharmaceutical Canada Corp - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: WellSpring Pharmaceutical Canada Corp



Your online Gateway to WellSpring Pharmaceutical Canada Corp in 2011

400 Iroquois Shore Road,
Oakville Ontario L6H 1M5 Canada
1-866-337-4500
Fax: 905-337-7239
http://www.wellspringcmo.com

About WellSpring Pharmaceutical Canada Corp

With WellSpring Pharmaceutical Contract Services our ability is your solution for manufacturing and packaging of virtually all finished non-sterile, solid and semi-solid dose products. We also provide clinical manufacturing, over-encapsulation, labeling, packaging, storage, distribution and returned goods management to support our clients’ most complex clinical trial requirements.


 


Our capabilities include blending, granulation, tablet compression, encapsulation, film coating, and topicals and liquids processing. Extensive packaging capabilities enable tablets or capsules to be bottled or blister-sealed and topical products can be supplied in jars and tubes. Our facility and quality systems have been successfully inspected by FDA and Health Canada.

Please visit WellSpring Pharmaceutical for manufacturing, packaging, analytical and distribution services for clinical and commercial supplies.  Contact us to arrange a convenient time to discuss how we can provide contract services supply chain solutions for virtually all finished non-sterile, liquids, semi-solids  and solid dosage form products.  WellSpring’s outstanding customer service and flexibility will ensure your supply chain needs are met.

 

New Products
and Releases

Brochure

 

For more information:

info@wellspringcmo.com

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here